Detalhe da pesquisa
1.
Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
Nephrol Dial Transplant
; 27(7): 2720-33, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22302208
2.
[The involvement of the renin-angiotensin system gene polymorphisms in coronary heart disease]. / Relevancia de los polimorfismos génicos del sistema renina-angiotensina en la enfermedad coronaria.
Rev Esp Cardiol
; 55(2): 92-9, 2002 Feb.
Artigo
em Espanhol
| MEDLINE | ID: mdl-11852019
3.
Simvastatin impairs growth hormone-activated signal transducer and activator of transcription (STAT) signaling pathway in UMR-106 osteosarcoma cells.
PLoS One
; 9(1): e87769, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24489959
4.
Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway.
J Biol Chem
; 277(51): 49389-96, 2002 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12384510
5.
The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values.
Clin Exp Hypertens
; 25(4): 209-20, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12797595
6.
Relevancia de los polimorfismos génicos del sistema renina-angiotensina en la enfermedad coronaria / The Involvement of the Renin-Angiotensin System Gene Polymorphisms in Coronary Heart Disease
Rev. esp. cardiol. (Ed. impr.)
; 55(2): 92-99, feb. 2002.
Artigo
em Es
| IBECS (Espanha) | ID: ibc-5684